Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 22:8:119.
doi: 10.3389/fncel.2014.00119. eCollection 2014.

Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives

Gabriele Deidda  1 , Ignacio F Bozarth  1 , Laura Cancedda  1
Affiliations
Review

Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives

Gabriele Deidda et al. Front Cell Neurosci. .

Abstract

During mammalian ontogenesis, the neurotransmitter GABA is a fundamental regulator of neuronal networks. In neuronal development, GABAergic signaling regulates neural proliferation, migration, differentiation, and neuronal-network wiring. In the adult, GABA orchestrates the activity of different neuronal cell-types largely interconnected, by powerfully modulating synaptic activity. GABA exerts these functions by binding to chloride-permeable ionotropic GABAA receptors and metabotropic GABAB receptors. According to its functional importance during development, GABA is implicated in a number of neurodevelopmental disorders such as autism, Fragile X, Rett syndrome, Down syndrome, schizophrenia, Tourette's syndrome and neurofibromatosis. The strength and polarity of GABAergic transmission is continuously modulated during physiological, but also pathological conditions. For GABAergic transmission through GABAA receptors, strength regulation is achieved by different mechanisms such as modulation of GABAA receptors themselves, variation of intracellular chloride concentration, and alteration in GABA metabolism. In the never-ending effort to find possible treatments for GABA-related neurological diseases, of great importance would be modulating GABAergic transmission in a safe and possibly physiological way, without the dangers of either silencing network activity or causing epileptic seizures. In this review, we will discuss the different ways to modulate GABAergic transmission normally at work both during physiological and pathological conditions. Our aim is to highlight new research perspectives for therapeutic treatments that reinstate natural and physiological brain functions in neuro-pathological conditions.

Keywords: GABA; GABA metabolism; GABAA receptor; cation chloride cotransporters; neurodevelopmental disorders.

PubMed Disclaimer

References

    1. Abramian A. M., Comenencia-Ortiz E., Vithlani M., Tretter E. V., Sieghart W., Davies P. A., et al. (2010). Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition. J. Biol. Chem. 285, 41795–41805 10.1074/jbc.M110.149229 - DOI - PMC - PubMed
    1. Adusei D. C., Pacey L. K., Chen D., Hampson D. R. (2010). Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Neuropharmacology 59, 167–171 10.1016/j.neuropharm.2010.05.002 - DOI - PubMed
    1. Ahn K., Gil R., Seibyl J., Sewell R. A., D'Souza D. C. (2011). Probing GABA receptor function in schizophrenia with iomazenil. Neuropsychopharmacology 36, 677–683 10.1038/npp.2010.198 - DOI - PMC - PubMed
    1. Akbarian S., Chen R. Z., Gribnau J., Rasmussen T. P., Fong H., Jaenisch R., et al. (2001). Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol. Dis. 8, 784–791 10.1006/nbdi.2001.0420 - DOI - PubMed
    1. Amir R. E., Van Den Veyver I. B., Wan M., Tran C. Q., Francke U., Zoghbi H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185–188 10.1038/13810 - DOI - PubMed